In direct ELISAs and Western blots, less than 1% cross-reactivity with recombinant human KLK-1, -3, -4, -5, -6, -7, -8, -10, -11, -12, -13, -14, and -15 is observed.
Reconstitute at 0.2 mg/mL in sterile PBS.
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK9 is a novel kallikrein with potential application for diagnosis, monitoring and therapeutics of various cancers including those of the breast, prostate and testis.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: Kallikrein-9; Kallikrein-like protein 3; kallikrein-related peptidase 9; KLK-9; KLK-L3
Gene Aliases: KLK-L3; KLK9; KLKL3
UniProt ID: (Human) Q9UKQ9
Entrez Gene ID: (Human) 284366
Molecular Function: annexin calcium-binding protein calmodulin enzyme modulator hydrolase intracellular calcium-sensing protein peptide hormone protease protease inhibitor receptor serine protease signaling molecule